Trial intelligence / Profile preview

Betamethasone pharmacokinetics and placental transfer in twin pregnancy

RBR-2v2mwkzPhase 3Completed

Sponsor
Faculdade de Medicina de Ribeirão Preto
Start
Mar 2018
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of betamethasone in preterm birth, sponsored by Faculdade de Medicina de Ribeirão Preto. Primary endpoints: Maternal betamethasone pharmacokinetics and Placental transfer of betamethasone. Started Mar 2018; status: completed.

02

Drugs

betamethasone
03

Conditions

preterm birth

Beyond the preview

Go deeper on RBR-2v2mwkz.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-2v2mwkz.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call